Login / Signup

S2DV: converting SMILES to a drug vector for predicting the activity of anti-HBV small molecules.

Jinsong ShaoQineng GongZeyu YinWenjie PanSanjeevi PandiyanLi Wang
Published in: Briefings Bioinform. (2022)
Keyphrases